1/25/2023 |
Pharmacy Program Updates - January 2023
|
11/22/2022 |
Pharmacy Program Updates - November 2022
|
09/22/2022 |
Committee Recruitment letter 2022 w/ Application
|
09/16/2022 |
Pharmacy Program Updates - September 2022
|
09/19/2022 |
Medicaid Pharmacy Coastal Storms
|
07/19/2022 |
Billing Guidance for Paxlovid (TM) prescribed by enrolled Pharmacist Renderers Under EUA
|
04/20/2022 |
Pharmacy Program Updates - April 2022
|
02/02/2022 |
Pharmacy Program Updates - COVID-19 At-Home Test Pharmacy Billing Guidance - February 2022
|
01/25/2022 |
Pharmacy Program Updates - January 2022
|
11/23/2021 |
Pharmacy Program Updates – November 2021
|
10/19/2021 |
Pharmacy P&T/DUR Committee Meeting Notice and Agendas for November 19, 2021
|
09/24/2021 |
Pharmacy Program Updates – September 2021
|
09/02/2021 |
Pharmacy Program Updates: Diagnosis Code Required on Ivermectin Claims
|
08/19/2021 |
Pharmacy P&T/DUR Committee Meeting Notice and Agendas for September 17, 2021
|
04/21/2021 |
Pharmacy Program Updates – April 2021
|
01/26/2021 |
Pharmacy Program Updates – January 2021
|
11/23/2020 |
Pharmacy Program Updates – November 2020
|
09/22/2020 |
Pharmacy Program Updates – September 2020 Revised
|
09/22/2020 |
Pharmacy Program Updates – September 2020
|
09/02/2020 | Pharmacy Program Updates – Diagnosis Code Required on MAT-Related Drug Claims |
09/02/2020 | Pharmacy Program Updates – Quantity Prescribed on Schedule II Claims |
08/17/2020 |
Pharmacy Program Updates – August 2020
|
07/13/2020 | Medicaid Pharmacist Enrollment and Billing Training |
06/09/2020 | Standing Order: Pharmacist Administration of COVID-19 Tests |
05/13/2020 | Pharmacy Program Updates – May 2020 |
04/23/2020 | Pharmacy Program Updates – April 2020 |
04/01/2020 | Pharmacy Program Updates – COVID-19 Preparedness #3 |
03/26/2020 | Pharmacy Program Updates – COVID-19 Preparedness #2 |
03/20/2020 | Pharmacy Program Updates – COVID-19 Preparedness #1 |
03/05/2020 | Pharmacy Program Updates – COVID-19 and Early Refills |
01/28/2020 | Pharmacy Program Updates – January 2020 |
11/25/2019 | Pharmacy Program Updates – November 2019 |
09/26/2019 | Pharmacy Program Updates – September 2019 |
08/30/2019 | Pharmacy Program Changes and Updates - SUPPORT Act |
08/22/2019 | Medically Necessary Early Refills due to Wildfires |
07/23/2019 | 2019 Cost of Dispensing Survey |
07/09/2019 | Pharmacy Program Updates - 2019 July |
05/02/2019 | Pharmacy Program Updates - 2019 May |
04/16/2019 | Dsuvia and Spravato Conditions of Payment |
01/31/2019 |
Alaska Medicaid Pharmacy Update - January 2019
|
12/07/2018 |
Alaska Medicaid Pharmacy Update - December 2018
|
10/09/2018 |
Alaska Medicaid Pharmacy Update - September 2018
|
09/10/2018 |
Pharmacy Program Updates - 2018 Fall
|
12/28/2017 |
Letter to Providers: Limit on Federal Financial Participation for Durable Medical Equipment in Medicaid
|
09/22/2017 |
Letter to Providers: HCV DAA PA Clinical Criteria for Use
|
09/22/2017 |
HCV DAA PA Clinical Criteria for Use - FINAL
|
09/01/2017 |
HCV DAA PA Clinical Criteria for Use (superseded by 09/22/2017 Final version)
|
03/31/2017 |
CMS-2345-FC Final Rule Effective April 1, 2017
|
03/24/2017
|
Opioid Claims ICD-10 Guidance for Pharmacies
|
03/21/2017
|
Alaska Medicaid Pharmacy Opioid Management Strategies and Initiatives
|
08/22/2016
|
Pharmacy Program Changes and Updates - August 2016
|
08/09/2016
|
Alaska Medicaid Pharmacy - Naloxone
|
07/27/2016
|
835 Electronic Remittance Advice Transmission Delay - Pharmacy Providers
|
07/05/2016
|
Drug Utilization Review Update - Direct Acting Antivirals
|
04/18/2016
|
New Federal Upper Limits for Multiple Source Drugs - Second Notice
|
04/01/2016
|
New Federal Upper Limits for Multiple Source Drugs
|
03/14/2016
|
Medicaid Policy Clarification: Cost of Gloves Used by Assisted Living Home Employees
|
06/29/2015
|
Pharmacy Program Changes and Updates - June 2015
|
04/29/2015
|
Pharmacy Program Changes and Updates - April 2015
|
02/17/2015
|
Pharmacy Preferred Drug List Update
|
02/02/2015
|
Pharmacy Program Changes and Updates - Winter 2015
|
01/29/2015
|
Pharmacy Program Update - Prior Authorization Pamphlet Regulations
|
12/23/2014
|
Pharmacy Program Changes and Updates - Fall 2014
|
07/24/2014
|
FDA Approved Covered Outpatient Drugs
|
05/07/2014
|
New State Maximum Allowable Cost - Effective 7/1/2014
|
04/22/2014
|
Regulation Changes: Outpatient Drugs and Pharmacy Claims
|
02/25/2014
|
Pharmacy Program Changes and Update – February 2014
|
12/17/2013
|
Pharmacy Program Changes and Update – December 2013
|
08/22/2013
|
Letter to Providers: Pharmacists and Prescribers Must be Enrolled in Alaska Medicaid to Prescribe for Medicaid Recipients
|
05/24/2013
|
Pharmacy Program Changes and Update – Summer 2013
|
05/09/2013
|
Pharmacy Program Changes and Update – May 2013
|
03/27/2013
|
Pharmacy Program Changes and Update – March 2013
|
01/24/2013
|
Pharmacy Program Changes and Update – Jan 2013
|
12/14/2012
|
Pharmacy Website Address Changes – Dec 2012
|
11/14/2012
|
Pharmacy Program Changes and Update - Nov 2012
|
10/01/2012
|
Atypical (2nd Generation) Antipsychotics - Clarification
|
06/11/2012
|
Brand Name Multisource Medication Claims and Atypical Antipsychotics Update - June 2012
|
05/15/2012
|
Pharmacy Program Changes and Update - May 2012
|
04/23/2012
|
Spring Update - 2012
|
02/21/2012
|
Pharmacy Program Changes and Update - Feb 2012 |
02/16/2012
|
Pharmacy Program Changes and Update - Winter 2012 |
02/10/2012
|
Opioid Theraputic Duplication Edits |
02/10/2012
|
Pharmacy Preferred Drug List Update |
01/10/2012
|
Myers and Stauffer Cost of Dispensing Survey Letter - Chain Pharmacy
|
01/10/2012
|
Myers and Stauffer Cost of Dispensing Survey Letter - Chain Pharmacy
|
01/10/2012
|
Myers and Stauffer Cost Dispensing Survey Letter - Independent Pharmacy
|
01/09/2012
|
Details Regarding NCPDP D.O Processing Changes for Pharmacy Claims: Update Letter
|
12/19/2011
|
Mediset Fee FAQ and Guidance Letter
|
12/13/2011
|
Details Regarding NCPDP D.O Processing Changes for Pharmacy Claims: Update Letter (revised 01/09/2012)
|
12/01/2011
|
Pharmacy Dispensing Fee Annual Prescription Volume Letter and Survey Form
|
11/21/2011
|
NCPDP D.0 Claims Processing: Update Letter
|
10/28/2011
|
Pharmacy Claims Reprocessing for Dispensing Fees - DOS: October 5, 2011 through October 21, 2011
|
09/26/2011
|
Pharmacy Coverage and Payment - New Prior Authorization and Quantity Limits
|
09/07/2011
|
Emergency regulations regarding reimbursement for Medisets: Effective 9/7/2011
|
08/31/2011
|
In-state pharmacy and dispensing prescriber payment regulation changes: Effective 9/7/2011
|
08/31/2011
|
Out of state pharmacy payment regulation changes: Effective 9/7/2011
|
08/01/2011
|
In-state pharmacy and dispensing prescriber payment regulation changes: Effective 9/7/2011 (revised 08/31/2011)
|
08/01/2011
|
Out of state pharmacy payment regulation changes: Effective 9/7/2011 (revised 08/31/2011)
|
07/22/2011
|
Opioid Quantity Limits Effective August 22, 2011
|
04/29/2011
|
Tobacco Cessation Medications and Counseling
|
04/15/2011
|
Prescribers must enroll with Alaska Medicaid
|
03/31/2011
|
Diabetic Durable Medical Equipment
|
11/03/2008
|
Pharmacy Updates 10-26-10
|
11/03/2008
|
NPI Compliance & the Prescriber Identifier
|
11/03/2008
|
NPI Required Effective October 31, 2007
|
11/03/2008
|
Alaska Medicaid Transition Period for Implementation of National Provider Identifier
(NPI)
|
04/14/2008
|
Billing Requirements for Drugs Administered in Outpatient Clinical
Settings
|
12/05/2005
|
Medicare Part D
|
10/28/2005
|
Pharmacy Cost Avoidance and Coordination of Benefits
|
09/13/2004
|
Implementation of NCPDP Partial Fills Functionality
|
06/11/2004
|
Preferred Drug List
|
12/09/2003
|
Implementation of NCPDP Version 5.1 Compound Segment
|
n/a
|
More letters
|